Results 211 to 220 of about 15,631 (257)

Efficacy of Albuterol in the Management of Bronchiolitis

Pediatrics, 1994
Objective. To examine the efficacy of albuterol (0.15 mg/kg per dose) in the management of bronchiolitis. Design. Randomized, double-blind, placebo-controlled outpatient clinical trial utilizing four study groups: nebulized albuterol, nebulized saline, oral albuterol, and oral placebo. Setting.
Thomas Permutt, James King, Anne Gadomski, Lisa Horton, Richard Lichenstein, Virginia Keane   +5 more
openaire   +3 more sources

Nebulized albuterol in acute bronchiolitis

The Journal of Pediatrics, 1990
In a double-blind, placebo-controlled trial, 40 infants between 6 weeks and 24 months of age who had a first episode of wheezing and other signs and symptoms of bronchiolitis were randomly assigned to receive either nebulized albuterol (0.15 mg/kg/dose) or placebo (saline solution) for two administrations 1 hour apart. The albuterol therapy resulted in
Eitan Kerem, Suzanne Schuh, Gerard J. Canny, Henry Levison, J. Reisman, Lea Bentur, Martin Petric   +6 more
openaire   +2 more sources

Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.

Allergy and Asthma Proceedings, 2017
BACKGROUND A novel, inhalation-driven, multidose dry powder inhaler (MDPI) that does not require coordination of actuation with inhalation has been developed.
C. Laforce, H. Taveras, H. Iverson, P. Shore   +3 more
semanticscholar   +1 more source

Unusual Vascular Reactions to Albuterol

Archives of Internal Medicine, 1984
Two patients experienced previously undescribed vascular reactions to albuterol sulfate inhalation. Features of the first reaction suggest mast-cell degranulation and were reversed by epinephrine. The second patient experienced severe postural hypotension corresponding to albuterol's duration of action.
Michael A. Passero, Alan Shurman
openaire   +3 more sources

Unintentional albuterol ingestion in children

Pediatric Emergency Care, 1994
This study was designed to determine the threshold dose for toxicity, the potential for serious medical complications, and the medical care required after unintentional albuterol ingestion in children. This study was prospective and descriptive. Data were obtained on pediatric albuterol ingestions evaluated emergently as reported to three regional ...
Douglas J. Borys, James F. Wiley, Henry A. Spiller, Edward P. Krenzelok   +3 more
openaire   +3 more sources

Albuterol syrup in the treatment of asthma

Journal of Allergy and Clinical Immunology, 1985
This study evaluated the administration of albuterol syrup (0.1 mg/kg/6 hr) or placebo to 2- to 6-year old children whose extrinsic asthma was treated with maintenance theophylline in a prerandomized, double-blind crossover study design. Albuterol/theophylline treatment produced peak expiratory flow rates 2 hours after administration that were ...
William E. Pierson, William E. Pierson, Clifton T. Furukawa, Clifton T. Furukawa, Shapiro Gg, Shapiro Gg, Bierman Cw, Bierman Cw   +7 more
openaire   +3 more sources

Continuous Spherical Crystallization of Albuterol Sulfate with Solvent Recycle System

, 2015
Spherical crystallization enables the direct preparation of crystal agglomerates of active pharmaceutical ingredients (APIs) with improved crystal handling properties.
K. Tahara, M. O’Mahony, A. Myerson
semanticscholar   +1 more source

Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.

Allergy and Asthma Proceedings, 2016
BACKGROUND Albuterol multidose dry powder inhaler (MDPI) with an integrated dose counter allows patients to track the number of remaining doses and to simplify dosing by eliminating the need to coordinate inhalation with actuation associated with metered-
J. Given, H. Taveras, H. Iverson
semanticscholar   +1 more source

Multiple‐Dose Albuterol Kinetics

The Journal of Clinical Pharmacology, 1986
Albuterol a beta‐adrenergic agonist bronchodilator, was studied in 12 healthy male volunteers to evaluate the steady‐state pharmacokinetics following oral administration of 4‐mg tablets, given every six hours for five days. The kinetics of albuterol were best described by a two‐compartment open model with first‐order absorption kinetics.
Menger Chung, Elaine Radwanski, Miryam Weisberger, Samson Symchowicz, Richard Gural, Mark L. Powell, James E. Patrick   +6 more
openaire   +3 more sources

Financial effect of converting ipratropium-albuterol therapy from inhalers to nebulizer treatments at an academic health system.

American Journal of Health-System Pharmacy, 2016
PURPOSE The results of a study to assess the financial impact of an automatic formulary substitution of ipratropium-albuterol nebulization solution for ipratropium-albuterol metered-dose inhalers (MDIs) at an academic health system are reported ...
Steven M Loborec, Shawn E. Johnson, Ellen A Keating   +2 more
semanticscholar   +1 more source